GREGORY OTT
Real Estate Commission in Philadelphia, PA
License number
Pennsylvania RS326097
Category
Real Estate Commission
Type
Real Estate Salesperson-Standard
Address
Address
Philadelphia, PA 19115
Personal information
See more information about GREGORY OTT at radaris.comName
Address
Phone
3086 Comfort Rd, New Hope, PA 18938
PO Box 196, Souderton, PA 18964
1163 Virginia Way, Quakertown, PA 18951
6 Rossiter Cir, New Hope, PA 18938
630 Cemetery St, Williamsport, PA 17701
Organization information
See more information about GREGORY OTT at bizstanding.comGREGORY OTT AGENCY
2448 Cottman Ave, Philadelphia, PA 19149
Industry:
Insurance Companies
Phone:
(215) 338-7331 (Phone)
Professional information
See more information about GREGORY OTT at trustoria.com
Associate Director, Medicinal Chemistry At Teva Pharmaceuticals
Associate Director, Medicinal Chemistry At Teva Pharmaceuticals
Position:
Associate Director, Medicinal Chemistry at Teva Pharmaceuticals
Location:
Greater Philadelphia Area
Industry:
Pharmaceuticals
Work:
Teva Pharmaceuticals
- West Chester, PA since Oct 2011
-
Associate Director, Medicinal Chemistry
Cephalon
Jan 2005 - Oct 2011
-
Associate Director
Bristol-Myers Squibb
2001 - 2005
-
Sr. Research Investigator
DuPont Pharmaceuticals
1999 - 2001
-
Senior Scientist
University of California, Berkeley
1997 - 1999
-
Post-Doctoral Fellow
Education:
University of Pennsylvania 1992 - 1997
Ph.D., Organic Chemistry The Johns Hopkins University 1988 - 1992
BA, Chemistry Shady Side Academy 1984 - 1988
Ph.D., Organic Chemistry The Johns Hopkins University 1988 - 1992
BA, Chemistry Shady Side Academy 1984 - 1988
Owner, Nationwide Ott &Amp; Associates, Inc.
Owner, Nationwide Ott &Amp; Associates, Inc.
Position:
Owner at Nationwide Ott & Associates, Inc.
Location:
Greater Philadelphia Area
Industry:
Insurance
Work:
Nationwide Ott & Associates, Inc.
-
Owner
Cyclic -Amino Acid Derivatives As Inhibitors Of Matrix Metalloproteases And Tnf-
Cyclic -Amino Acid Derivatives As Inhibitors Of Matrix Metalloproteases And Tnf-
US Patent:
6743807, Jun 1, 2004
Filed:
Mar 16, 2001
Appl. No.:
09/811233
Inventors:
Jingwu Duan - Newark DE
Gregory Ott - Philadelphia PA
Lihua Chen - Wilmington DE
Carl Decicco - Kennett Square PA
Zhonghui Lu - Wilmington DE
Gregory Ott - Philadelphia PA
Lihua Chen - Wilmington DE
Carl Decicco - Kennett Square PA
Zhonghui Lu - Wilmington DE
Assignee:
Bristol-Myers Squibb Pharma Company - Princeton NJ
International Classification:
A61K 3147
US Classification:
514314, 546172, 546175
Abstract:
The present application describes novel cyclic -amino acid derivatives of formula I: or pharmaceutically acceptable salt forms thereof, wherein ring B is a 5-7 membered cyclic system containing from 0-2 heteroatoms selected from O, N, NR , and S(O) , and 0-1 carbonyl groups and the other variables are defined in the present specification, which are useful as metalloprotease and/or as TNF- inhibitors.
Gregory Charles Ott, Philadelphia PA - Lawyer
Gregory Charles Ott, Philadelphia PA - Lawyer
Address:
ARAMARK Corporation
1101 Market St, Philadelphia 19107
(215) 238-3293
1101 Market St, Philadelphia 19107
(215) 238-3293
Licenses:
Pennsylvania - Active 2001
Cyclic Β-Amino Acid Derivatives As Inhibitors Of Matrix Metalloproteases And Tnf-Α
Cyclic Β-Amino Acid Derivatives As Inhibitors Of Matrix Metalloproteases And Tnf-Α
US Patent:
6984648, Jan 10, 2006
Filed:
Feb 13, 2004
Appl. No.:
10/779539
Inventors:
Zhonghui Lu - Wilmington DE, US
Matthew E. Voss - Lincoln Univ. PA, US
Jingwu Duan - Newark DE, US
Gregory Ott - Philadelphia PA, US
Lihua Chen - Wilmington DE, US
Carl Decicco - Kennett Square PA, US
Matthew E. Voss - Lincoln Univ. PA, US
Jingwu Duan - Newark DE, US
Gregory Ott - Philadelphia PA, US
Lihua Chen - Wilmington DE, US
Carl Decicco - Kennett Square PA, US
Assignee:
Bristol-Myers Squibb Pharma Company - Princeton NJ
International Classification:
A61K 31/47, A61K 31/445, C07D 215/02, C07D 413/00, C07D 211/68
US Classification:
514314, 544127, 546166, 546135, 546194, 514318
Abstract:
The present application describes novel cyclic β-amino acid derivatives of formula I:
or pharmaceutically acceptable salt forms thereof, wherein ring B is a 5-7 membered cyclic system containing from 0-2 heteroatoms selected from O, N, NR, and S(O), and 0-1 carbonyl groups and the other variables are defined in the present specification, which are useful as metalloprotease and/or as TNF-α inhibitors.
